BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 113430
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.113430
Table 1 Baseline characteristics and investigations at enrollment, n (%)
Characteristics
Recurrent wheezing (n = 33)
Non-recurrent wheezing (n = 96)
P value
Male13 (39.39)46 (47.92)0.425
Age (months)27.68 ± 14.9530.61 ± 14.520.330
Age category (months)
> 36-6010 (30.30)26 (27.08) 0.477
> 24-3613 (39.39)30 (31.25)
> 12-248 (24.24)24 (25.00)
≤ 122 (6.06)16 (16.67)
Preterm birth2 (7.69)8 (9.20)0.585
Low birth weight2 (7.69)9 (10.47)0.425
Cesarean birth15 (60.00)50 (60.98)0.555
Allergic rhinitis7 (21.21)4 (4.17)0.006
Atopic dermatitis4 (12.12)12 (12.50) 0.612
History of food/drug allergy2 (6.06)3 (3.12)0.602
Urban residency23 (69.70)73 (76.04)0.493
Underlying disease14 (42.42)23 (23.96)0.048
Hematologic disease4 (12.12)4 (4.17)0.202
Maternal smoking during pregnancy2 (9.09)11 (11.58)0.542
Secondhand smoke 52 (22.73)23 (4.21)0.560
Parental asthma4 (16.00)0 (0.00)0.002
Daycare attendance17 (70.83)53 (55.79)0.247
Hct33 ± 35.5596 ± 36.430.129
WBC14420.30 ± 5268.5211057.81 ± 4466.33< 0.001
Neutrophil (%)50.37 ± 20.8950.37 ± 18.860.112
ANC8965.52 ± 5118.235843.84 ± 3702.22
Lymphocyte (%)32.72 ± 18.4339.76 ± 18.420.061
ALC4240.184535.910.660
Eosinophil (%)2.20 ± 1.831.03 ± 1.34< 0.001
AEC322.85 ± 318.11113.80 ± 151.50< 0.001
Eosinophilia (AEC > 500)9 (27.27)3 (3.12)< 0.001
Platelet count361393.90 ± 106626.40339863.20 ± 99551.720.295
Anemia 7 (21.21)14 (14.58)0.416
Pet ownership0.250
    None17 (80.95)83 (89.25)
    Dog1 (4.76)6 (6.45)
    Cat3 (14.29)3 (3.23)
    Both dog and cat0 (0.00)1 (1.08)
Post-RSV infection12 (38.71)58 (65.91)0.011
Influenza A0 (0.00)2 (2.33)0.539
Post-LRTI21 (63.64)20 (20.83)< 0.001
Post-URTI19 (57.58)47 (48.96)0.425
Table 2 Univariable logistic regression analysis of risk factors for recurrent wheezing
Risk factors
OR
95%CI
P value
Male1.420.63-3.170.398
Age (months)
> 36-60ReferenceReference
> 24-361.230.43-2.990.811
> 12-240.870.29-2.560.796
≤ 120.330.06-1.780.179
Preterm birth1.220.24-6.110.813
Low birth weight1.400.28-6.940.678
Cesarean birth0.960.38-2.400.930
Allergic rhinitis6.191.68-22.800.006
Atopic dermatitis0.970.29-3.230.955
History of food/drug allergy2.000.32-12.520.459
Urban residency1.380.57-3.320.472
Underlying disease2.341.02-5.390.046
Hematologic disease3.170.75-13.480.118
Maternal smoking during pregnancy0.760.16-3.720.739
Secondhand smoke0.920.31-2.770.883
Daycare attendance1.920.73-5.070.185
Anemia 1.580.58-4.320.376
Eosinophilia (AEC > 500 cells/μL)1.001.00-1.01< 0.001
Pet 1.570.77-3.200.217
Post-RSV infection0.330.14-0.760.010
Post-LRTI6.652.80-15.77< 0.001
Post-URTI1.410.64-3.140.394
Table 3 Multivariable logistic regression analysis of potential risk factors for recurrent wheezing
Potential risk factors
Adjust odds ratio
95%CI
P value
Male1.130.80-1.600.482
Age (months)
> 36-60ReferenceReference
> 24-361.120.71-1.750.625
> 12-242.381.50-3.78< 0.001
≤ 12NANANA
Preterm birth1.661.07-2.580.024
Allergic rhinitis1.501.04-2.170.031
Atopic dermatitis0.510.26-0.980.044
Urban residency1.681.19-2.380.003
Hematologic disease2.430.78-7.570.126
Maternal smoking during pregnancy1.600.71-3.600.254
Secondhand smoke0.500.26-0.980.045
Daycare attendance1.190.85-1.660.315
Eosinophilia (AEC > 500 cells/μL)3.291.57-6.910.002
Pet 1.040.57-1.890.907
Post-RSV infection1.220.83-1.810.312
Post-LRTI1.821.20-2.760.005
Post-URTI0.810.57-1.140.232